Cholangiocarcinoma — Trials

Cholangiocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

760 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 210
Recruiting: 120
Ph III recruiting: 7
Growth YoY: +17.4%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (106)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07120295	Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible Accessories	recruiting	Phase 4	75	University of Colorado, DenverOTHER	1	Sep 3, 2026	clinicaltrials
NCT07486713	Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies	recruiting	Phase 4	16	Rigel PharmaceuticalsINDUSTRY	1	Aug 11, 2026	clinicaltrials